Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer

Approved

Classifications

MinEdu publication type
A1 Journal article (peer-reviewed)
Definition
Article
Target group
Scientific
Peer reviewed
Peer-reviewed
Article type
Journal article
Host publication type
Journal

Authors of the publication

Number of authors
14
Authors
Abdelmalek, Carine M.; Hu, Zexi; Kronenberger, Thales; Küblbeck, Jenni; Kinnen, Franziska J.M.; Hesse, Salma S.; Malik, Afsin; Kudolo, Mark; Niess, Raimund; Gehringer, Matthias; Zender, Lars; Witt-Enderby, Paula A.; Zlotos, Darius P.; Laufer, Stefan A.

Publication channel information

Title of journal/series
Journal of medicinal chemistry
ISSN (print)
0022-2623
ISSN (electronic)
1520-4804
ISSN (linking)
0022-2623
Publication forum ID
61000
Publication forum level
3
Internationality
Yes

Detailed publication information

Publication year
2022
Reporting year
2022
Journal/series volume number
65
Journal/series issue number
6
Page numbers
4616-4632
DOI
10.1021/acs.jmedchem.1c01646
Language of publication
English

Co-publication information

International co-publication
Yes
Co-publication with a company
No

Availability

Classification and additional information

MinEdu field of science classification
3122 Cancers, 317 Pharmacy

Source database ID

WoS ID
WOS:000790749000013
Scopus ID
2-s2.0-85127234999
Other database ID
35286086